Intercept Pharmaceuticals, Inc. (ICPT) financial statements (2023 and earlier)

Company profile

Business Address 10 HUDSON YARDS, 37TH FLOOR
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments85470653436415689628
Cash and cash equivalents85587043704433
Short-term investments 412583393345646595
Restricted cash and investments1085    
Receivables48423826179 
Inventory, net of allowances, customer advances and progress billings998732 
Inventory998732 
Prepaid expense    15610
Other undisclosed current assets352181713(1)14
Total current assets:502546721482448708642
Noncurrent Assets
Inventory, Noncurrent998    
Operating lease, right-of-use asset6  
Property, plant and equipment36510161110
Other noncurrent assets61213    
Other undisclosed noncurrent assets0771620204
Total noncurrent assets:25353427363114
TOTAL ASSETS:527580755509484739656
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1581078140423346
Accounts payable18251912774
Accrued liabilities60472877730
Employee-related liabilities25272620271911
Interest and dividends payable988    
Other undisclosed accounts payable and accrued liabilities47      
Debt  6    
Deferred revenue and credits2262
Other undisclosed current liabilities97274736140 
Total current liabilities:1671791621141047947
Noncurrent Liabilities
Long-term debt and lease obligation540561532371356341 
Long-term debt, excluding current maturities540561532371356341 
Liabilities, other than long-term debt4895846
Deferred revenue and credits1346
Other liabilities48946  
Total noncurrent liabilities:5445685413763643466
Total liabilities:71174770349046842454
Stockholders' equity
Stockholders' equity attributable to parent(184)(167)521916315602
Common stock0000000
Additional paid in capital2,3092,2342,1761,8001,4871,4261,300
Accumulated other comprehensive loss(3)(2)(1)(2)(1)(3)(2)
Accumulated deficit(2,490)(2,398)(2,123)(1,779)(1,470)(1,108)(696)
Total stockholders' equity:(184)(167)521916315602
TOTAL LIABILITIES AND EQUITY:527580755509484739656

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues363313252180131253
Revenue, net131253
Cost of revenue(3)(5)(4)(3)(1)  
Cost of goods and services sold   (3)(1)  
Gross profit:360307248177130253
Operating expenses(416)(539)(560)(465)(467)(427)(232)
Other undisclosed operating income0  31  
Operating loss:(56)(231)(312)(285)(336)(403)(229)
Nonoperating income (expense)(36)(44)(32)(24)(25)(10)3
Investment income, nonoperating      (6)
Other nonoperating income249754 
Interest and debt expense17(48)(41)(31)(29)(14) 
Other undisclosed income from continuing operations before equity method investments, income taxes 4841312914 
Loss from continuing operations before equity method investments, income taxes:(75)(275)(345)(309)(360)(413)(226)
Other undisclosed loss from continuing operations before income taxes(17)      
Net loss available to common stockholders, diluted:(91)(275)(345)(309)(360)(413)(226)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(91)(275)(345)(309)(360)(413)(226)
Other comprehensive income (loss)(0)(1)1 (358)(413)(228)
Comprehensive loss:(92)(276)(344)(309)(719)(826)(455)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (1)   
Comprehensive loss, net of tax, attributable to parent:(92)(276)(344)(311)(719)(826)(455)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: